About
Jennifer Bergheiser is Chief Business Officer at eGenesis, a biotechnology company developing engineered organs for human transplantation. Her public bio describes more than 20 years in biopharma strategy, product planning, business development, venture investing, and management consulting, including experience at Domain Associates, Centocor/Johnson & Johnson, Acureon Pharmaceuticals, and Accenture. She has also served as a board observer for TargetRx and Proxima Therapeutics.
Areas of interest
biotechxenotransplantationorgan transplantationbiopharmaceutical strategybusiness developmentventure-backed therapeuticscommercial product developmentimmunology